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BLOOD PRESSURE (BP) NORMALLY VARIES DURING 
DIFFERENT PHYSIOLOGIC STATES AND DECLINES 
BY 10% TO 20% AT NIGHTTIME DURING SLEEP, com-
pared with BP at daytime during wakefulness.1,2 A noctur-
nal BP decrease less than 10% of daytime BP is defined as 
“nondipping.”1,2 Nondipping has been described in patients 
with refractory or malignant hypertension, pheochromocy-
toma, cardiac transplantation, congestive heart failure and, 
chronic renal insufficiency.3-8 Nondipping has also been 
shown in patients with clinically symptomatic obstructive 
sleep apnea, regardless of hypertension status.9 This nondip-
ping has been described as a marker for future development 
of hypertension in those who are normotensive at baseline. 
In patients with hypertension, nondipping has been associated 
with worse cardiovascular prognosis and increased target or-
gan damage, including left ventricular hypertrophy, microal-
buminuria, myocardial infarction, angina, ischemic stroke, 
and cardiovascular death.10-20
Sleep-disordered breathing (SDB) has been associated with 
hypertension and cardiovascular disease (CVD) in several pop-
ulation-based studies.21-24 Researchers postulate that nocturnal 
BP elevations during apneic episodes, possibly secondary to 
increased sympathetic activity from arousals or hypoxia, may 
result in a higher occurrence of nondipping in those with SDB. 
Since nondipping has been implicated in increased CVD and 
end-organ disease, the increased prevalence of nondipping in 
SDB has been postulated as one of the mechanisms by which 
SDB contributes to increased CVD.25
Currently, data on the association of SDB and nocturnal 
nondipping are limited mostly to cross-sectional studies of 
patients with sleep apnea syndrome.5,26-28 Cross-sectional as-
sociations of SDB and nondipping suggest, but cannot provide 
conclusive evidence for, a causal role of SDB in nondipping. 
Therefore, we performed longitudinal analyses of 24-hour 
ambulatory BP recordings on a sample of Wisconsin Sleep 
Cohort Study participants to investigate whether SDB is pro-
spectively associated with the development of nocturnal non-
dipping over a 7.2 years average follow-up period. We also 
examined the effects of potential confounding or interacting 
factors including age, sex, body mass index (BMI) at baseline 
and at follow-up; current smoking, alcohol consumption, hy-
pertension, habitual sleep time, reported sleepiness from the 
baseline visit; time interval between baseline SDB and fol-
low-up 24-hour BP measurements; self-reported continuous 
positive airway pressure (CPAP) use, history of physician-
diagnosed CVD (myocardial infarction, congestive heart fail-
ure, or cerebrovascular accidents) at baseline and follow-up; 
and antihypertensive medication use at any time during the 
follow-up time period.
Sleep DiSorDereD Breathing anD nocturnal BlooD preSSure
Longitudinal Association of Sleep-Disordered Breathing and Nondipping of 
Nocturnal Blood Pressure in the Wisconsin Sleep Cohort Study
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Study objectives: The association of sleep-disordered breathing 
(SDB) and blunting of normal nocturnal lowering of blood pressure (BP) 
(nondipping) has only been examined cross-sectionally. The purpose 
of this study is to investigate whether SDB is prospectively associated 
with nondipping.
Methods: The longitudinal association between SDB and incident non-
dipping was examined in a subsample of 328 adults enrolled in the 
Wisconsin Sleep Cohort Study who completed 2 or more 24-hour am-
bulatory BP studies over an average of 7.2 years of follow-up. SDB 
identified by baseline in-laboratory polysomnography was defined by 
apnea-hypopnea index (AHI) categories. Systolic and diastolic nondip-
ping was defined by systolic and diastolic sleep-wake BP ratios > 0.9. 
All models were adjusted for age, sex, body mass index at baseline 
and follow-up, smoking, alcohol consumption, hypertension, sleep time, 
length of follow-up time, and antihypertensive medication use.
results: There was a dose-response increased odds of developing 
systolic nondipping in participants with SDB. The adjusted odds ratios 
(95% confidence interval) of incident systolic nondipping for baseline 
AHI 5 to < 15 and AHI ≥ 15, versus AHI <5, were 3.1 (1.3-7.7) and 
4.4 (1.2-16.3), respectively (P trend = 0.006). The adjusted odds ratios 
(95% confi dence interval) of incident diastolic nondipping for corre-
sponding SDB categories were not statistically significant: 2.0 (0.8-5.6) 
and 1.3 (0.2-7.1).
conclusions: Our longitudinal findings of a dose-response increase 
in development of systolic nondipping of BP with severity of SDB at 
baseline in a population-based sample provide evidence consistent 
with a causal link. Nocturnal systolic nondipping may be a mechanism 
by which SDB contributes to increased cardiovascular disease.
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MethoDS
Study Sample
Informed consent documents and study protocols, described 
in detail previously,29 for the ongoing Wisconsin Sleep Cohort 
Study were approved by the University of Wisconsin-Madison 
Health Sciences Institutional Review Board. Briefly, the study 
sample consisted of a probability sample of employees of 4 
Wisconsin state agencies, aged 30 to 60 years, invited to un-
dergo an overnight study protocol at baseline and follow-up 
studies at 4-year intervals. The Cohort was initiated in 1989 
and has provided the opportunity for adding ancillary studies. 
In this study, a protocol for 24-hour ambulatory BP monitor-
ing (ABPM) was added to the overnight sleep-study protocol 
in 1991 with sequential enrollment. From a total of 491 par-
ticipants with baseline ABPM studies, 328 men and women 
successfully completed 2 or more 24-hour ABPM follow-up 
studies. Reasons for lack of follow-up data on the remaining 
163 subjects with baseline data only included refusal (mostly 
due to inconvenience), laboratory scheduling difficulties, and 
inadequate data.
Of the 328 subjects with multiple studies, we excluded 
those whose follow-up period was less than 3 years (n = 18). 
We then excluded participants who were on antihypertensive 
medications or were nondippers at their baseline ABPM study 
(assessed separately for systolic and diastolic analyses) to cre-
ate an inception cohort, free of the condition of nocturnal BP 
nondipping, to follow for the development of new nondipping 
over a range of 3 to 13.2 years. According to these criteria, 
83 participants were excluded from the systolic analyses, and 
68 were excluded from the diastolic analyses. The remaining 
sample comprised 227 subjects to follow for development of 
systolic BP nondipping and 242 to follow for development of 
diastolic BP nondipping.
Sleep studies were conducted at the University of Wiscon-
sin, General Clinical Research Center, in a sleep-laboratory 
suite with home-like bedrooms. Data collection relevant to this 
analysis included 24-hour ABPM, body habitus measurements, 




Full overnight in-laboratory 18-channel nocturnal polysom-
nography was performed, and sleep stages were identified using 
standard methods.30 SDB was summarized by the apnea-hypo-
pnea index (AHI, the average number of apnea and hypopnea 
events per hour of sleep). Apnea was defined as a complete ces-
sation of airflow for longer than 10 seconds at the mouth and 
nose, and hypopnea as a decrease in respiratory effort with a 
greater than 4% drop in Sao2. Three SDB severity levels, rep-
resenting typical clinical cutpoints, were examined: no or mini-
mal SDB (AHI < 5), mild SDB (AHI 5 to < 15), and moderate 
to severe SDB (AHI ≥ 15).
24-hour aBpM
Typically, the baseline 24-hour ABPM was performed within 
6 weeks (mean: 11, SD = 8 weeks) following the overnight sleep 
study, with the Accutracker II (SuntechMedical Instruments/
Eutectics Electronics, Raleigh, NC), a 24-hour BP monitoring 
device that uses a modified auscultatory method. Details of the 
study protocol and ABPM quality data have been previously 
published.23 ABPM readings were obtained at random intervals 
averaging every 15 to 20 minutes during wakefulness and every 
30 minutes during sleep. Activity, posture, bedtime, and time 
on awakening from sleep were recorded by participants on dia-
ries. ABPM data were edited using pre determined established 
criteria.23
Individual mean BPs were computed by averaging ABPM 
measurements during sleep and wake defined by participants’ 
recorded sleep and wake times, not by preset nighttime and 
daytime cutoffs. Systolic BP nondipping is defined as mean 
systolic sleep BP/mean systolic wake BP ratio greater than 
0.9. Diastolic BP nondipping is defined similarly using mean 
diastolic sleep and wake BP. New incidence of BP nondipping 
status was prospectively examined with 227 participants for 
systolic BP and 242 for diastolic BP over the entire follow-up 
time period. An outcome variable was created to represent no 
change in dipping status (no development of nondipping over 
the entire follow-up) or incident nondipping (development of 
nondipping during any subsequent follow-up visit). Those in-
dividuals who fluctuated between dipping, nondipping, and 
dipping again were excluded (n = 7 for systolic BP and n = 3 
for diastolic BP). Of the 220 remaining participants examined 
for systolic BP, 141 had 1 follow-up ABPM study, 69 had 2 
follow-up studies, and 10 had 3 follow-up studies. Of the 239 
participants examined for diastolic BP, 155 had 1 follow-up 
ABPM study, 68 had 2 follow-up studies, and 16 had 3 follow-
up studies. The mean follow-up period and range for each AHI 
category were similar: 7.1 (3.1-13.2) years for AHI 0 to 5, 7.5 
(3.2-12.6) years for AHI 5 to < 15, and 7.2 (3.0-11.3) years for 
AHI ≥15, indicating that a potential bias due to unequal follow-
up periods by SDB status was unlikely. However, a variable for 
the follow-up interval was used in all analyses to account for 
individual differences.
other Data collection
BMI was calculated from measured body weight and height 
(kg/m2) at both baseline and follow-up study. Participants com-
pleted a questionnaire on the night of the sleep study regarding 
the following covariates: current smoking, alcohol consump-
tion (number of alcoholic drinks per week), use of CPAP for 4 
or more nights per week, sleepiness (based on response to the 
question “Many people have periods of low energy or fatigue, 
but, during a typical day, do you experience excessive sleepi-
ness when it is difficult to fight an uncontrollable urge to fall 
asleep?”), antihypertensive medication use, and reported usual 
sleep duration on weekdays and weekends. Habitual sleep time 
in hours was calculated as the weighted average of weekday 
and weekend sleep time (i.e., [5 × weekday + 2 × weekend]/ 7). 
A variable was created to represent any new antihypertensive 
medication use over the course of the study. Hypertension was 
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defined as systolic BP ≥ 140 mm Hg and/or diastolic BP ≥ 90 
mm Hg, as measured in the overnight laboratory or as use of 
antihypertensive medication.
Data analysis
Logistic regression was performed to estimate odds ra-
tios (OR) and 95% confi dence interval (�I) for the relation-C
ship between SDB and incident nondipping over an average 
of 7.2 years follow-up, for systolic nondipping and diastolic 
nondipping separately. In addition to baseline AHI, the mod-
els included the following covariates: age, sex, BMI, current 
smoking, hypertension, and alcohol consumption based on 
data from baseline visit, BMI at follow-up, follow-up time 
between baseline SDB and follow-up 24 hour BP measure-
ments, habitual sleep time, and whether or not an individual 
was on antihypertensive medication ever during the follow-
up time period. We investigated potential confounding fac-
tors and interactions of the covariates and SDB, including an 
interaction term for AHI severity level and sleepiness. Finally, 
we analyzed additional models: (1) with and without partici-
pants who were on antihypertensive medications at any subse-
quent visits during the follow-up period(n = 42), (2) with and 
without participants who reported they used CPAP (n = 11) to 
investigate the effect of use of antihypertensive medication 
or CPAP on the association between SDB and development 
of nondipping, and (3) with and without those with history of 
physician-diagnosed myocardial infarction, congestive heart 
failure, or cerebrovascular accidents at baseline and follow-
up.
All analyses were performed with SAS software, release 
9.1.31 Logistic regression model coefficients were assessed by 
Wald χ2 tests, and 2-tailed P values of < 0.05 indicated statisti-
cal significance. SDB severity was entered as a categorical vari-
able, except when testing for trend.
reSultS
Table 1 shows the key descriptive statistics for the respon-
dents in the study sample with follow-up 24-hour BP data (n = 
328) versus the total eligible sample (N = 491). There were no 
substantial differences in the main predictor and outcome vari-
ables between the two groups except for a higher percentage of 
baseline systolic nondipping in the total sample. Table 2 depicts 
the baseline participants’ characteristics and covariates used in 
the analyses stratified by AHI category.
Over the follow-up period of an average of 7.2 years, 18% 
developed systolic nondipping and 11% developed diastolic 
nondipping. SDB severity at baseline was significantly associ-
ated with the onset of nondipping in systolic BP. Table 3 shows 
the unadjusted and adjusted ORs for development of both new 
systolic and new diastolic nondipping in AHI 5 to <15 and AHI 
≥ 15 versus AHI < 5. Relative to AHI < 5, the association with 
systolic nondipping was seen for AHI 5 to <15 and for AHI 
≥ 15 in a dose-response fashion: the ORs (95% �I) adjusted 
for age, sex, BMI, current smoking, hypertension, and alcohol 
consumption at baseline visit, BMI at follow-up, time between 
baseline SDB and follow-up 24 hour BP measurements, habit-
ual sleep time, and ever having been on antihypertensive medi-
cation were 3.1 (1.3, 7.7) and 4.4 (1.2, 16.3), respectively (P 
trend = 0.006). Removing participants who reported CPAP use 
(n = 11) showed no significant difference: the ORs for incident 
systolic BP nondipping over an average of 7.2-years-follow-
up period were 2.7 (1.1, 6.8) and 4.3 (0.9, 19.8) for AHI 5 to 
< 15 and AHI ≥ 15 versus AHI <5, respectively. In addition, 
excluding those who reported antihypertensive medication use 
at any visit (n = 42) did not substantially change ORs for sys-
tolic nondipping; 3.3 (1.1, 9.5) and 6.1 (1.2, 29.9) for AHI 5 
to <15 and AHI ≥ 15 versus AHI < 5, respectively. Removing 
participants with reported CVD (n = 8) (myocardial infarction, 
congestive heart failure and strokes) did not change the results 
significantly: the ORs for developing new systolic BP nondip-
ping for AHI 5 to < 15 and AHI ≥ 15 versus AHI < 5 in those 
with no CVD were slightly higher at 3.9 (1.5, 10.1) and 4.6 
(1.2, 18.3), respectively.
In the analysis of diastolic nondipping, there was no dose-
response relationship seen with increased SDB severity: com-
Table 1—Comparison of Baseline Characteristics of Participants 
Who had Repeat 24-Hour BP Studies Versus All Those Eligible in 
the Sample for Longitudinal Data Analysis
Characteristic Baseline Sample
 With follow-up Overall
 24-h BP data
 (n = 328) (n = 491)
Mean age, y 49.4 49.4
Male sex, % 62.5 59.8
Mean BMI, kg/m2 29.3 29.9
Current smoker, % 16.8 16.7
Mean alcohol consumption,
  number of drinks/wk 3.7 3.8
Antihypertensive
  medication users, % 15.5 15.9
Median AHI, events/h 1.7 1.5
AHI ≥ 15 events/h, % 9.2 9.9
Nondipping systolic BP, %  14.6 18.2
Nondipping diastolic BP, %  7.3  9.8
BP refers to blood pressure; BMI, body mass index; AHI, apnea-
hypopnea index.
Table 2—Study Sample �haracteristics Stratified by AHI Sever-
ity (n = 328)
Baseline Characteristic AHI Category
	 <	5	 5-15	 ≥	15
Age, y  48 (8) 52 (8) 52 (8)
Male sex, %  56 72 91
BMI, kg/m2  28 (5) 31 (5) 34 (5)
Current smoker, % 15 23 19
Alcohol, number of drinks/wk  3 (5) 4 (6) 5 (8)
Antihypertensive medication users, % 13 23 22
Median AHI, events/h 0.8 8.2 26.2
Nondipping systolic BP, % 13 20 19
Nondipping diastolic BP, % 6 6 16
Data are presented as mean (SD) or percentage; apnea-hypopnea 
index (AHI) is presented as median. BP refers to blood pressure.
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can elderly patients was related to sleep apnea.28 Furthermore, 
treatment of sleep apnea with CPAP has been shown to lower 
nighttime systolic BP more than daytime BP.33-34 We did not 
see an association between diastolic nondipping and SDB 
in our study. The effect of SDB as well as its treatment with 
CPAP on blood pressure in both normotensive and hyperten-
sive subjects has been more consistently seen with systolic BP 
than with diastolic BP.21,26,32,33 In general, systolic BP is more 
labile, whereas diastolic BP is less sensitive to acute physi-
ologic insults, such as apnea and hypopnea episodes, during 
sleep.
Our findings, as well as prior findings, of an association be-
tween SDB and nocturnal nondipping are important because of 
demonstrated associations between nondipping and advanced 
target organ damage and poor cardiovascular prognosis.11-19 
SDB, too, has been associated with poor cardiovascular out-
comes, including hypertension, myocardial infarction, coronary 
artery disease, strokes, and congestive heart failure.20-24 Thus, 
our data suggest that nondipping may be one of several pos-
sible mechanisms by which such outcomes may be initiated 
or exacerbated in SDB. The acute respiratory breathing events 
of SDB—apneas and hypopneas—cause temporary elevations 
of BP, likely via pathways initiated with intrathoracic pressure 
perturbations, as well as via hypoxia/hypercapnia and arousal 
with sympathetic activation.35 It is possible that these repeated 
bouts of sympathetic activation prevent complete normalization 
of BP in the time between events, causing systolic BP to fail 
to fully experience the nocturnal dip typically seen in persons 
without SDB. This failure to experience normal dipping adds 
to the amassing evidence that SDB has a causal role in CVD, 
possibly via multiple pathways.36,37
Our findings of the longitudinal association of SDB and 
systolic nondipping are unique. First, our data were based on 
24-hour ABPM using actual sleep and wake times recorded by 
participants and not arbitrary preset times. This allowed for bet-
ter accuracy in defining sleep and wake BP. Second, our study 
was performed in a population-based cohort, enabling us to 
prospectively determine the association of SDB and nondip-
ping in a nonclinical population with occult or undiagnosed 
pared to AHI < 5, AHI 5 to < 15 and AHI ≥ 15 had a similar un-
adjusted risk of developing new diastolic nondipping: 2.3 (1.0, 
5.6) and 1.5 (0.4, 5.4), respectively, and a similar adjusted risk 
of developing new diastolic nondipping: 2.0 (0.7, 5.6) and 1.1 
(0.2, 6.3), respectively.
We did not find any interactions between SDB and our cova-
riates, including reported sleepiness and baseline hypertension 
status. The effect of SDB on developing systolic and diastolic 
nondipping was the same for sleepy versus nonsleepy partici-
pants and for those who were hypertensive versus normoten-
sive. We also examined the change in AHI from baseline to 
follow-up. AHI change was not associated with development 
of new nondipping.
DiScuSSion
In this population-based sample, we found a significant 
longitudinal association between baseline SDB status and de-
velopment of nocturnal BP systolic nondipping among par-
ticipants who initially had normal nocturnal BP dipping. This 
was a strong association, with individuals who had mild SDB 
(AHI between 5 and 15 events/h) at baseline having a 3-fold in-
creased odds of developing systolic nondipping, compared with 
persons with no or minimal SDB at baseline (AHI < 5 events/h) 
over an average follow-up period of 7.2 years. The association 
showed a dose-response gradient: persons with a baseline AHI 
≥ 15 had a 4.4 fold greater odds of developing systolic nondip-
ping, compared with those with no or minimal SDB at baseline. 
These unique findings suggest the role of SDB in the develop-
ment of systolic nondipping.
Similar results have been reported in cross-sectional stud-
ies consisting of patients with sleep apnea.26-28 Pankow et al 
reported an increased prevalence of hypertension and nondip-
ping, determined by a 24-hour ABPM with preset sleep and 
wake periods, in 93 patients with moderate and severe SDB, 
determined by oxygen saturation index.26 Loredo et al found 
that, in a highly selective sample of 44 subjects with sleep ap-
nea, 84% were nondippers.27 Ancoli-Israel et al reported that 
the increased preponderance of nondipping in African Ameri-
Table 3—The Association of Sleep-Disordered Breathing with Incidenta Systolic and Diastolic Nondipping Over an Average of 7.2-Year 
Follow-Up Period
AHI Category Total sample Incident nondipping, OR (95% CI)
  overall, no. no. (%) Unadjusted Adjustedb
Systolic Nondipping (n = 220)
 < 5 162 22 (13.5) 1.0 (reference) 1.0 (reference)
 5 to < 15 39 12 (30.8) 2.8 (1.3, 6.4) 3.1 (1.3, 7.7)
 ≥ 15 19 6 (33.3) 2.9 (1.0, 8.5) 4.4 (1.2, 16.3)
Diastolic Nondipping (n = 239)
 < 5 175 18 (10.3) 1.0 (reference) 1.0 (reference)
 5 to < 15 43 9 (20.9) 2.3 (1.0, 5.6) 2.0 (0.7, 5.6))
 ≥ 15 21 3 (14.3) 1.5 (0.4, 5.4) 1.1 (0.2, 6.3)
AHI refers to apnea-hypopnea index; OR, odds ratio; �I, confidence interval.
aAmong participants with baseline normal blood pressure (BP) dipping and no use of antihypertensive medication, followed over an average 
of 7.2 years.
bAll models adjusted for age, sex, body mass index at baseline and follow-up, current smoking, hypertension, habitual sleep time and alcohol 
consumption from the baseline visit; time between baseline SDB and follow-up 24-h BP; and whether or not an individual was on antihyper-
tensive medication ever during the follow-up time period.
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quence, strengthens the evidence that SDB has a causal role in 
the development of systolic nondipping.
Our study has a few limitations. We included participants us-
ing CPAP in the main analyses because we could not be certain 
that their SDB was being treated optimally (e.g., adequate com-
pliance with CPAP use or CPAP pressure level). Our compari-
sons of analyses including CPAP users versus excluding CPAP 
users demonstrated no meaningful differences. Although this 
seems to contradict the published data of the effect of CPAP 
on nighttime BP,26,32-34 our study was not designed or powered 
to look at the effect of CPAP use on dipping status. Finally, we 
did not follow-up all participants who had a baseline 24-hour 
BP study. However, our analysis of the population character-
istics (Table 1) in the total eligible follow-up sample versus 
the actual follow-up sample showed no differences except for 
a higher percentage of baseline systolic nondipping in the to-
tal sample. Although the proportion of nondippers was slightly 
higher in the total sample, all nondippers were excluded for the 
longitudinal analysis. It is possible that the difference reflects 
better health among those who underwent multiple, follow-up, 
24-hour BP measurement studies and may have led to fewer 
cases of nondipping. Although this possible difference would 
reduce study power, it would not lead to an overestimation of 
the association.
Our findings of a strong longitudinal association of SDB 
with nocturnal systolic nondipping of BP have clinical and pub-
lic health relevance, since SDB and hypertension both are very 
prevalent in the general population.29,38 The development of sys-
tolic BP nondipping, a well-established CVD risk, in those with 
mild to moderate SDB underscores the importance of diagnos-
ing SDB even in its milder forms (an apnea hypopnea index of 5 
to 15). Our findings support the need to consider the presence of 
occult SDB as one of the causes of secondary hypertension, as 
stated in the most recent (Seventh) Report of the Joint National 
Committee on Prevention, Detection, Evaluation and Treatment 
of High Blood Pressure,38 especially in those whose 24 hour BP 
studies yielded blunted nocturnal dipping. Further research is 
necessary to determine if nondipping attributed to SDB results 
in increased CVD in our cohort.
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